Niti Aayog invites bids for setting up Advance Chemistry Cell manufacturing facilities under PPP

By: |
November 11, 2020 8:54 PM

Globally, manufacturers are investing in these new generation technologies at commercial scale to cater to the expected boom in battery demand through 2030.

Niti Aayog, Niti Aayog news, Niti Aayog latest, Niti Aayog updates, Modi govt, manufacturing updates, new ventureNiti Aayog is playing a key role in COVID-19 vaccine rollout and its member V K Paul is heading the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).

Government think tank Niti Aayog has invited bids for setting up Advance Chemistry Cell manufacturing facilities under public private partnerships. Bids have been sought under the proposed National Programme on Advance Chemistry Cell (ACC) Battery Storage. According to draft model bid document posted on Niti Aayog’s website, the government intends to develop giga-scale advance cell manufacturing for domestic application and promotion of diverse energy sources to ensure overall energy security.

“A bidder selected through this RFP, to be eligible for this subsidy, would have to commit to set-up an Advance Chemistry Cell manufacturing facility of minimum 5 GWh capacity and establish an Advance Chemistry Cell manufacturing facility with value-addition of minimum 25 per cent at the mother unit level and minimum 60 per cent overall,” the document said. The facilities are proposed to be set up under Public Private Partnership (PPP). Advance Chemistry Cells (ACCs) are the new generation advance storage technologies that can store electric energy either as electrochemical or as chemical energy and convert it back to electric energy as and when required.

Globally, manufacturers are investing in these new generation technologies at commercial scale to cater to the expected boom in battery demand through 2030. The government on Wednesday approved a Production-Linked Incentive (PLI) scheme for ten key sectors, including ACC battery, telecom, automobiles and pharmaceuticals, taking the total outlay for such incentives to nearly Rs 2 lakh crore over a five-year period.

The scheme will help encourage domestic manufacturing, reduce imports and generate employment as the government works to bolster economic growth. The financial outlay for the new scheme will be Rs 1,45,980 crore. The five-year PLI scheme was approved by the Union Cabinet on Wednesday.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1NLC India witnesses capacity addition of 517 MW in FY21
2Road trip: Ocean on one side, mountains on another; Bangalore to Goa, via coffee estates of Chikmagalur
3Hotspots: Public Wi-Fi network gathers pace